Mechanisms Of Age-related Changes in Transcriptional Regulation, TCR Repertoire, and Cytokine Expression
Mechanisms Of Age-related Changes in Transcriptional Regulation, TCR Repertoire, and Cytokine Expression
批准号:
9348193
负责人:
Nan-ping Peter Weng
金额:
$52.38万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffinityAgeAgingAmino AcidsAntigensBindingBiochemicalCD4 Positive T LymphocytesCD8B1 geneCell physiologyCellsChIP-seqChromatinComplexConsensusCytomegalovirusDevelopmentDiseaseDissociationEnsureEpitopesExhibitsFutureGene ExpressionGenesGeneticGenetic TranscriptionGoalsHLA-A2 AntigenHigh-Throughput Nucleotide SequencingHumanImmuneImmune responseImmune systemImmunityIndividualInfluenza A virusLengthMachine LearningMemoryMethodsMicroRNAsPortraitsPost-Transcriptional RegulationRoleStructureStudy SubjectT cell responseT memory cellT-Cell ReceptorT-LymphocyteTimeTissue-Specific Gene ExpressionTranscriptional RegulationVariantViralViral AntigensVirus Diseasesage relatedbasecomparativecytokinedifferential expressionhistone modificationinterestmicrobialnext generation sequencingpathogenpersonalized medicinepreference
中文摘要
不同的T细胞受体(TCR)库对于控制病毒感染至关重要。然而,关于人类TCR库的一般信息和定义的病毒抗原有限。我们利用高通量测序(HTS)和单细胞配对TCR分析对CD4+和CD8+的TCR谱进行了综合分析,并对巨细胞病毒的pp65495503 (NLV)和甲型流感病毒的M15866 (GIL)这两个显性病毒表位的CD8+ TCR谱进行了特异性分析。我们对CD4+和CD8+ T细胞的TCR谱进行了比较分析。CD4+ T细胞的TCR多样性在1.8-8.2 x105之间,平均是CD8+ T细胞的3-4倍。此外,CD4+(0.3%)和CD8+ (1.3%) T细胞之间的TCR序列几乎没有重叠。进一步的分析表明,CD4+和CD8+ T细胞对CDR3中的某些氨基酸表现出明显的偏好,这一点通过支持向量机分类器进一步证实,表明CD4+和CD8+ T细胞中的TCR CDR3存在明显的可识别的差异。最后,我们确定了6-12%的独特tcr与不同的V基因共享相同的CDR3。总之,我们的发现揭示了CD4+和CD8+ T细胞之间TCR库的独特特征,并可能用于评估T细胞免疫能力。
英文摘要
A diverse T cell receptor (TCR) repertoire is essential for controlling viral infections. However, information on human TCR repertoires in general and to defined viral antigens is limited. We performed a comprehensive analysis of TCR repertoires of CD4+ and CD8+, and CD8+ TCR repertoires specific for two dominant viral epitopes: pp65495503 (NLV) of cytomegalovirus and M15866 (GIL) of influenza A virus using the high-throughput sequencing (HTS) and single-cell paired TCR analysis. We provided a comparative analysis of the TCR repertoires of CD4+ and CD8+ T cells. TCR diversity of CD4+ T cells ranges from 1.8-8.2 x105 and is 3-4 times greater on average than that of CD8+ T cells in each study subject. Furthermore, there was little overlap in TCR sequences between CD4+ (0.3%) and CD8+ (1.3%) T cells. Further analysis showed that CD4+ and CD8+ T cells exhibited distinct preferences for certain amino acids in the CDR3, and this was further confirmed by a support vector machine classifier, suggesting there are distinct and discernible differences between TCR CDR3 in CD4+ and CD8+ T cells. Finally, we identified 6-12% of the unique TCRs that share an identical CDR3 with different V genes. Together, our findings reveal the distinct features of the TCR repertoire between CD4+ and CD8+ T cells and could potentially be used to evaluate the competency of T cell immunity.
For antigen-specific CD8+ TCR repertoires, we identified thousands of new NLV- and GIL-specific TCR and TCR sequences, as well as dozens of distinct CDR3 and CDR3 consensus motifs. This diversity is substantially greater than previously described for T cell responses to single viral epitopes, both for private and public TCR clonotypes, and exhibited a high degree of individual variations (12028,000 clonotypes per subject). However, diversity is effectively restricted by preferential V-J combinations, CDR3 lengths, and CDR3/CDR3 pairings. We further found that GIL-specific, but not NLV-specific, TCRs exhibited a surprisingly wide range of binding affinities, with dissociation constants (KDs) from 2 to 200 M. Finally, we determined the crystal structures of two unrelated GIL-specific TCRs in complex with GILHLA-A2 and two TCR-NLV- HLA-A2 complexes. These structures provide an explanation of the lower diversity of GIL-specific than NLV-specific repertoires. Remarkably, these two anti-viral TCR repertoires occupied 0.220% of the total CD8+ TCR repertoire, ensuring broad and robust T cell responses to single epitopes. Our comprehensive genetic, biochemical, and structural portrait of two different anti-viral T cell responses may contribute to the future development of predictors of immunity or disease at the personal level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR ANALYSIS OF HUMAN NAIVE AND MEMORY T CELLS
-
批准号:6288747
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Mechanisms Of Age-related Changes in Transcriptional Regulation in lympphocytes
-
批准号:9551862
-
项目类别:
-
资助金额:$23.8万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Regulation and function of telomerase in T cells
-
批准号:9348182
-
项目类别:
-
资助金额:$26.19万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Role of Telomere and telomerase In Human Lymphocyte Function and Aging
-
批准号:10007356
-
项目类别:
-
资助金额:$44.62万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Mechanisms Of Age-related Changes in Transcriptional Regulation in lympphocytes
-
批准号:10007357
-
项目类别:
-
资助金额:$57.37万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Mechanisms Of Age-related Changes in Transcriptional Regulation in lympphocytes
-
批准号:10252561
-
项目类别:
-
资助金额:$29.57万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
TCR repertoire: size, diversity, and function
-
批准号:10913085
-
项目类别:
-
资助金额:$40.15万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Role of Telomere and telomerase In Human Lymphocyte Function and Aging
-
批准号:10913140
-
项目类别:
-
资助金额:$31.34万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
TCR repertoire: size, diversity, and function
-
批准号:10007349
-
项目类别:
-
资助金额:$44.62万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Molecular Analysis of Human Naive and Memory T Cells
-
批准号:6431464
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Molecular Analysis Of Human Naive And Memory T Cells
-
批准号:6668156
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Flow Cytometry Laboratory (Scientific Core)
-
批准号:10007539
-
项目类别:
-
资助金额:$25.5万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Flow Cytometry Laboratory (Scientific Core)
-
批准号:10460046
-
项目类别:
-
资助金额:$6.31万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Molecular Analysis Of Human Naive And Memory T Cells
-
批准号:6530381
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Flow Cytometry Laboratory (Scientific Core)
-
批准号:10250956
-
项目类别:
-
资助金额:$7.89万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
TCR repertoire: size, diversity, and function
-
批准号:10252551
-
项目类别:
-
资助金额:$11.83万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Mechanisms Of Age-related Changes in Transcriptional Regulation in lympphocytes
-
批准号:10913141
-
项目类别:
-
资助金额:$59.74万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Flow Cytometry Laboratory (Scientific Core)
-
批准号:10913227
-
项目类别:
-
资助金额:$3.92万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Mechanisms Of Transcriptional Regulation in Memory lymphocyte Response and Aging
-
批准号:9147344
-
项目类别:
-
资助金额:$47.41万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
Role of Telomere In Human Lymphocyte Function and Aging
-
批准号:9147343
-
项目类别:
-
资助金额:$29.63万
-
财政年份:--
-
负责人:Nan-ping Peter Weng
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: